Treatment patterns and markers in bladder cancer in Russia
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks at how bladder cancer is treated and what biological markers are present in patients in Russia. If you join, you may help doctors learn more about which treatments work best based on your tumor type.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You're 18 years or older.
- You have a confirmed diagnosis of urothelial bladder cancer (the most common type).
- Your cancer is non-muscle invasive, muscle invasive, or has spread (metastatic).
- You have a tumor tissue sample (FFPE) that can be tested in a lab.
- You haven't been in any other treatment trials since your diagnosis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects tissue and blood samples from people diagnosed with early-stage bladder cancer (tumors that have not invaded the bladder muscle). The goal is to use these samples for research that could improve future diagnosis and treatment. It may be an opportunity to contribute to medical research.
This study tests a urine test that may help find bladder cancer early without needing invasive procedures. It is for people with high-grade or high-risk non-muscle-invasive bladder cancer who are receiving or have received BCG treatment.
This trial uses special MRI scans and tiny markers placed in the bladder to better plan bladder chemoradiation. The goal is to help target treatment more accurately and improve how well it can be delivered.
This study looks at tumor and blood samples from people with muscle-invasive bladder cancer to find markers that help predict how the disease will progress. It aims to improve personalized treatment for those with this specific stage of bladder cancer.
This trial studies a redesigned surgical instrument used during bladder tumor removal, to see if it can improve how the removed tissue samples are collected. It may help future patients by supporting better study of bladder tissue during cancer care.
This study looks for specific DNA changes in bladder cancer tumors using a precise test. It aims to better understand the disease and may help guide future treatment choices.
Hear when a new Bladder Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.